C12N 2760/16011
Orthomyxoviridae
C12N2760/16011 (Orthomyxoviridae) appears on 2,319 US grants and 3,649 published applications in this corpus.
Search patents in C12N- Granted patents
- 2,319
- Published applications
- 3,649
- Assignees
- 1,379
- Inventors
- 5,574
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 4 | 0 |
| 1978 | 3 | 0 |
| 1979 | 4 | 0 |
| 1980 | 7 | 0 |
| 1981 | 2 | 0 |
| 1982 | 7 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 6 | 0 |
| 1986 | 5 | 0 |
| 1987 | 6 | 0 |
| 1988 | 6 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 6 | 0 |
| 1992 | 8 | 0 |
| 1993 | 2 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 18 | 0 |
| 1997 | 32 | 0 |
| 1998 | 46 | 0 |
| 1999 | 35 | 0 |
| 2000 | 37 | 0 |
| 2001 | 39 | 7 |
| 2002 | 34 | 36 |
| 2003 | 30 | 81 |
| 2004 | 33 | 86 |
| 2005 | 26 | 73 |
| 2006 | 25 | 77 |
| 2007 | 38 | 106 |
| 2008 | 35 | 111 |
| 2009 | 58 | 158 |
| 2010 | 48 | 186 |
| 2011 | 64 | 177 |
| 2012 | 67 | 189 |
| 2013 | 98 | 180 |
| 2014 | 114 | 184 |
| 2015 | 129 | 163 |
| 2016 | 131 | 198 |
| 2017 | 127 | 192 |
| 2018 | 143 | 172 |
| 2019 | 149 | 174 |
| 2020 | 129 | 155 |
| 2021 | 106 | 143 |
| 2022 | 100 | 170 |
| 2023 | 85 | 161 |
| 2024 | 98 | 217 |
| 2025 | 100 | 145 |
| 2026 | 54 | 108 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2760/16111Influenzavirus a, i.e. influenza a virusIndexing code2,000
- C12N 2760/16211Influenzavirus b, i.e. influenza b virusIndexing code500
- C12N 2760/16034Use of virus or viral component as vaccineIndexing code315
- C12N 2760/16022New viral proteins or individual genes, new structural or functional aspects ofIndexing code185
- C12N 2760/16051Methods of production or purification of viral materialIndexing code100
- C12N 2760/16071Demonstrated in vivo effectIndexing code49
- C12N 2760/16311Influenzavirus c, i.e. influenza c virusIndexing code47
- C12N 2760/16061Methods of inactivation or attenuationIndexing code37
All 15 subgroupsShow fewer
- C12N 2760/16023Virus like particles [vlp]Indexing code35
- C12N 2760/16021Viruses as suchIndexing code25
- C12N 2760/16041Use of virus, viral particle or viral elements as a vectorIndexing code24
- C12N 2760/16032Use of virus as therapeutic agent, other than vaccineIndexing code7
- C12N 2760/16033Use of viral protein as therapeutic agent other than vaccineIndexing code7
- C12N 2760/16031Uses of virus other than therapeutic or vaccineIndexing code1
- C12N 2760/16088For redistributionIndexing code0
Recent patents
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Virus-like particles containing CST1 protein and toxoplasma vaccine using same1 Sep 2026US 12,721,886 B2University-Industry Cooperation Group of Kyung Hee University
- Coronavirus and influenza compositions and methods for using them25 Aug 2026US 12,714,744 B2
- Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)25 Aug 2026US 12,714,745 B2Baylor Research Institute
- Method for prevention and treatment of viral disease25 Aug 2026US 12,714,746 B2Morehouse School of Medicine
- Differential coating of microprojections and microneedles on arrays8 Oct 2026US 2026/0306611 A1Vaxxas Pty Limited
- Influenza ehead immunogens1 Oct 2026US 2026/0295029 A1The Scripps Research Institute
- Improved alum-anchored immunogens1 Oct 2026US 2026/0295039 A1Massachusetts Institute of Technology
- Universal avian flu vaccine (aiv)1 Oct 2026US 2026/0297137 A1DEI Biopharma
- Influenza virus vaccines24 Sep 2026US 2026/0284174 A1Glaxosmithkline Biologicals SA
Most cited
By later US patents
- Modified vaccinia virus298US 4,603,112 AHealth Research, Inc. · 1986
- Frozen piercing implements and methods for piercing a substrate284US 8,784,385 B2The Invention Science Fund I, LLC · 2014
- Modified vaccinia virus and methods for making and using the same264US 4,769,330 AHealth Research, Inc. · 1988
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Method for immunizing animals with synthetically modified vaccinia virus240US 4,722,848 AHealth Research, Inc. · 1988